AI, Biotech & Health: Where Innovation Meets Investing

SummaryIn this episode, Catherine and Melissa are joined by Eden Rahim, a Portfolio Manager at Next Edge Capital. We explore the dynamic world of biotech investing, the impact of AI on medicine development, and advanced options trading strategies. We discuss recent breakthroughs in Alzheimer's treatment, CRISPR technology, and how to generate yield through options, providing valuable insights for investors and health enthusiasts alike.Chapters00:00 Introduction and guest background01:11 History of biotech industry and cycles04:36 Biotech market recovery and current outlook06:07 Factors causing biotech volatility07:43 What is biotech and how it differs from pharma09:43 Blockbuster drugs and their impact on biotech11:51 M&A activity and industry growth16:06 Recent developments in Alzheimer's treatments18:16 Ownership and development of Alzheimer's drugs19:58 Advances in gene editing and CRISPR technology23:13 AI's role in drug repurposing and discovery26:13 Risks and rewards in biotech investing27:09 Key factors in biotech stock selection38:21 Biotech as an investment opportunity and ETFs40:03 Interest in CRISPR and gene editing43:51 Regulatory challenges and future of CRISPR45:19 Longevity and biotech innovations48:01 Options trading strategies and yield generation52:30 Practical options trading insights54:14 Closing remarks and future discussionsHost descriptions:Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.If you would like to join our email list, please reach out to [email protected] and let us know.